Sean Bohen

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Shane Kovacs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean Bohen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. President and CEO, Director Common Stock 237,650 $6,682,718 $28.12 26 Dec 2025 Direct
Olema Pharmaceuticals, Inc. President and CEO, Director Stock Option (Right to Buy) 650,000 28 Feb 2025 Direct

Insider Reports Filed by Sean Bohen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OLMA Olema Pharmaceuticals, Inc. 26 Dec 2025 1 $0 4 President and CEO, Director 30 Dec 2025, 16:05
OLMA Olema Pharmaceuticals, Inc. 28 Feb 2025 1 $0 4 PRESIDENT AND CEO, Director 03 Mar 2025, 16:15
OLMA Olema Pharmaceuticals, Inc. 09 Dec 2024 4 -$986,365 4 PRESIDENT AND CEO, Director 11 Dec 2024, 19:52
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2024 1 $0 4 PRESIDENT AND CEO, Director 05 Feb 2024, 17:30
OLMA Olema Pharmaceuticals, Inc. 20 Nov 2023 4 -$824,134 4 PRESIDENT AND CEO, Director 22 Nov 2023, 19:00
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2023 1 $0 4 President and CEO, Director 02 Feb 2023, 16:29
OLMA Olema Pharmaceuticals, Inc. 21 Sep 2022 1 $0 4/A PRESIDENT AND CEO, Director 23 Sep 2022, 17:35
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2022 1 $0 4 PRESIDENT AND CEO, Director 03 Feb 2022, 18:02
OLMA Olema Pharmaceuticals, Inc. 14 Oct 2021 4 -$128,243 4 PRESIDENT AND CEO, Director 15 Oct 2021, 18:44
OLMA Olema Pharmaceuticals, Inc. 27 Sep 2021 3 -$27,392 4 PRESIDENT AND CEO, Director 29 Sep 2021, 19:56
OLMA Olema Pharmaceuticals, Inc. 07 Sep 2021 6 -$76,669 4 PRESIDENT AND CEO, Director 09 Sep 2021, 16:25
OLMA Olema Pharmaceuticals, Inc. 01 Sep 2021 3 -$21,972 4 PRESIDENT AND CEO, Director 03 Sep 2021, 17:16